Verified Clinical Trials and Chubb Form Strategic Alliance to Enhance Clinical Trial Safety and Data Integrity
核心洞察
Verified Clinical Trials (搜索) and Chubb (搜索) announced a strategic alliance to enhance research subject safety and improve data quality through proactive risk management in clinical trials.
The partnership combines VCT's proprietary subject registry technology with Chubb (搜索)'s global insurance expertise to detect and prevent duplicate enrollment and protocol violations.
The alliance aims to reduce preventable operational, financial, and regulatory risks while supporting stronger clinical trial outcomes and ultimately benefiting drug development.
Verified Clinical Trials (搜索) (VCT), the global leader in clinical trial subject registry solutions, and Chubb (搜索) have announced a strategic alliance focused on enhancing research subject safety, improving data quality, strengthening study integrity, and supporting successful clinical trial outcomes. The partnership represents a significant advancement in proactive risk management for the clinical research industry.
Addressing Critical Clinical Trial Challenges
The alliance targets a longstanding and underrecognized challenge in clinical research: the inability to reliably examine a participant's research history to confirm eligibility. VCT's clinical trial subject registry solutions are designed to detect and help prevent duplicate enrollment and other important protocol violations at the time of screening—issues that can compromise research subject safety, affect data quality, create operational and regulatory challenges, and increase the risk of study failure.
"VCT addresses a longstanding and underrecognized challenge in clinical research: the inability to reliably look into a participant's research history to confirm eligibility," said Lee Farrow, EVP, Life Sciences Industry Practice Leader at Chubb (搜索). "This alliance with VCT reflects a shared focus on improving research subject safety, study integrity, and overall trial performance."
Comprehensive Risk Management Approach
Chubb (搜索)'s partnership with Verified Clinical Trials (搜索) is part of a broader clinical trial risk management approach. As the leading global underwriter of clinical trials, Chubb brings extensive expertise in tailoring insurance solutions for life sciences companies, with the scale and international capabilities to support pharmaceutical and biotechnology companies ranging from emerging innovators to some of the largest in the world.
The alliance provides Chubb (搜索) clients with an additional layer of protection against adverse events (搜索) (AEs), serious adverse events (搜索) (SAEs), protocol deviations, and compromised data quality associated with duplicate or undisclosed study participation.
Key Benefits and Impact
The strategic alliance offers six primary benefits to the clinical research ecosystem:
Enhanced Research Subject Safety: The partnership helps reduce the risk of duplicate or overlapping study participation that may contribute to adverse events (搜索), drug interactions (搜索), and other safety concerns.
Improved Data Quality: The alliance supports cleaner, more reliable study data for stronger analysis, decision-making, and regulatory submissions.
Greater Study Integrity: The collaboration helps reinforce protocol compliance and protect against violations that can undermine trial validity.
Reduced Risk Exposure: The partnership assists sponsors, CROs, and sites in mitigating preventable operational, financial, regulatory, and potential liability risks.
Stronger Potential for Clinical Trial Success: The alliance supports better-protected studies with a higher likelihood of meeting research objectives.
Broader Public Benefit: The partnership helps support the development of safer, more effective drugs and therapies for patients and communities.
Industry Leadership Perspectives
Dr. Mitchell Efros, Co-Founder & CEO at Verified Clinical Trials (搜索), emphasized the fundamental importance of the alliance's mission. "Research subject safety and data integrity are fundamental to every successful clinical trial," he said. "This alliance with Chubb (搜索) represents an important opportunity to help bring greater protection, stronger oversight, and added value to the clinical research ecosystem. Ultimately, the broader public stands to benefit as well, as safer, more effective drugs and therapies can be developed and brought forward with greater confidence for patient use."
Kerri Weingard, Co-Founder, VP and Global COO of Verified Clinical Trials (搜索), highlighted the proactive nature of the partnership. "This alliance with Chubb (搜索) represents a meaningful advancement in how the industry approaches risk - moving from reactive to proactive safeguards," she said. "By combining VCT's real-time subject verification capabilities with Chubb's global risk management expertise, we are helping to create a more secure, transparent, and reliable clinical trial ecosystem that ultimately benefits sponsors, sites, and, most importantly, patients."
Technology and Global Reach
VCT operates a secure global database trusted by research sites, sponsors, and CROs to help improve research subject safety, strengthen protocol compliance, and protect data integrity. The company's proprietary subject registry technology provides real-time subject verification capabilities that complement Chubb (搜索)'s global risk management expertise.
Chubb (搜索) operates in 54 countries and territories, providing comprehensive insurance solutions including commercial and personal property and casualty insurance, personal accident and supplemental health insurance, reinsurance and life insurance. The company employs approximately 45,000 people worldwide and is listed on the New York Stock Exchange as a component of the S&P 500 index.
The alliance represents an important step forward in advancing proactive risk management in clinical trials and underscores the value of collaboration between insurers and clinical trial technology leaders working to improve clinical research outcomes worldwide.